Real‐World Response and Survival Outcomes and Treatment Patterns in Patients With Extensive Stage Small‐Cell Lung Cancer Receiving Third‐Line Treatment

ABSTRACT Background Patients with small‐cell lung cancer (SCLC) primarily present with extensive stage (ES) disease and poor 5‐year survival. There are few treatment options and limited data on outcomes in third‐line (3L) ES SCLC to quantify unmet medical needs. This chart review evaluated real‐worl...

Full description

Saved in:
Bibliographic Details
Main Authors: Jair Bar, Qingqing Xu, Sudeep Karve, Pooja Hingorani, Amin A. Virani, Neal E. Ready
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Cancer Reports
Subjects:
Online Access:https://doi.org/10.1002/cnr2.70289
Tags: Add Tag
No Tags, Be the first to tag this record!